SEC Form 4 · accession 0001209191-18-049450
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — President & CEO · Director
Period of report
Sep 1, 2018
Accepted (ET)
Sep 5, 2018 · 1:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2018 | F | 3,306 | $14.00 | D | 192,061 | D | |
| Common Stock | holding | — | — | — | 14,238 | I | By the Aron M. Knickerbocker Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.